Jeff Liter

Company: Luminary Therapeutics

Job title: President & Chief Executive Officer

Seminars:

Panel Discussion: Discussing the Application & Opportunities to Progress Gamma Delta T Therapies in a Competitive Therapeutic Landscape 4:15 pm

Discussing opportunities and challenges to achieve investor, physician, and pharmaceutical industry buy-in to progress to commercialization Debating the need to embrace engineering, streamline process development and widen the patient pool to secure strong clinical results and achieve VC backing Developing gamma delta T-specific technologies to enhance R&D, clinical translation, and process development to advance through…Read more

day: Conference Day Two